Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease - Wikidata - awgldk - TriplyDB

Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease

Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease

http://www.wikidata.org/entity/Q58758199

about

Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease

http://www.wikidata.org/entity/Q58758199

description

article published in the Proce ...... f the United States of America

@en

article publié dans les Procee ...... f the United States of America

@fr

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Functional characterization of ...... ment of CNS autoimmune disease

@en

Functional characterization of ...... ment of CNS autoimmune disease

@nl

type

label

Functional characterization of ...... ment of CNS autoimmune disease

@en

Functional characterization of ...... ment of CNS autoimmune disease

@nl

prefLabel

Functional characterization of ...... ment of CNS autoimmune disease

@en

Functional characterization of ...... ment of CNS autoimmune disease

@nl

P1433

Q58758199-1B205AC1-9E0D-4AE3-9062-EEFF5FA09B29

P1476

Q58758199-AADECE41-F6AF-4FA3-B7F2-92142159D2C1

P2093

Q58758199-2591E177-E94B-49CC-BAD5-BFB335D3AAF6

Q58758199-641E7898-3DC1-4B6D-B532-318C5606DB8E

Q58758199-7A9E8B12-13F1-4C8C-826D-233C68317988

Q58758199-7ACEB167-392E-4967-A303-5E0AAA0D9625

Q58758199-B906BD3C-7AAC-4310-8E21-1C30DB385625

Q58758199-BF2F33D1-87B0-42DB-B638-A127741280EB

Q58758199-C7302FB9-1385-4AB6-ADAA-48E7B432974B

Q58758199-E6330F07-BD7F-42BB-830F-B5D5CD719D24

P2860

Q58758199-17FBC49E-13F6-4A30-ADDC-133F217DCD4C

Q58758199-1A6DEA4E-FA00-49F0-A6B3-83B1F341F267

Q58758199-218F1456-A8F7-454A-B727-C35CD00BBE79

Q58758199-21BF5ECA-997C-4FA1-8341-8ABE3D20C98B

Q58758199-2DA33A3D-B0E1-495D-8941-0F6651F48066

Q58758199-43AD3781-EDFE-45DA-BF41-EE4915AAD96D

Q58758199-459CDEED-D589-4BF3-B449-AFA55A8011C9

Q58758199-49845B0E-C41A-4CD1-8F35-BFF4C813831B

Q58758199-50DA6270-EBCE-4CAC-87A6-F5B43BA878E3

Q58758199-60349664-DCB9-43A8-BBD0-56D0514221B4

P304

Q58758199-6404E1FF-D140-49CF-9712-1AB2C5E75DC7

P31

Q58758199-E50B6DE2-4047-4870-B919-0E5E4AA69ADB

P356

Q58758199-A0168594-4F45-4D1F-A49A-3906FAF6493B

P407

Q58758199-685F1589-C799-477C-9B96-282C3E28CABC

P433

Q58758199-6F6A33F0-62C1-40B1-BD0C-BF811316C8C2

P478

Q58758199-3DBC49A5-7874-4616-A670-62C9905EB585

P50

Q58758199-28816FA9-469D-4C12-9220-816CBAB67471

Q58758199-DC8C9663-3F6F-4EE2-B1AF-665BCC7CB1AD

P577

Q58758199-6C78399F-4E2C-4775-B2F9-934076FED42E

P698

Q58758199-792E2FE0-7518-41E9-9525-42D9919DEB3B

P932

Q58758199-9D5B3C12-120C-45FB-B77E-17F8B9FF3AD3

P356

PNAS.1810470115

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Functional characterization of ...... ment of CNS autoimmune disease

@en

P2093

Claude C A Bernard

http://www.w3.org/2001/XMLSchema#string

Darius Häusler

http://www.w3.org/2001/XMLSchema#string

Klaus Lehmann-Horn

http://www.w3.org/2001/XMLSchema#string

Linda Feldmann

http://www.w3.org/2001/XMLSchema#string

Martin S Weber

http://www.w3.org/2001/XMLSchema#string

Scott S Zamvil

http://www.w3.org/2001/XMLSchema#string

Sebastian Torke

http://www.w3.org/2001/XMLSchema#string

Wolfgang Brück

http://www.w3.org/2001/XMLSchema#string

P2860

The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.

Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.

Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders.

Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response.

Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

P304

9773-9778

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1810470115

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Gildas Lepennetier

Silke Häusser-Kinzel

P577

2018-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30194232

http://www.w3.org/2001/XMLSchema#string

P932

6166805

http://www.w3.org/2001/XMLSchema#string